%0 Journal Article
%T The acute hepatic flare in a patient with chronic hepatitis C infection receiving pegylated interferon alpha 2b and ribavirin
%A Hayati Demiraslan
%A Zeynep T¨¹re
%A Ay£¿eg¨¹l Ulu K£¿l£¿£¿
%J Journal of Microbiology and Infectious Diseases
%D 2012
%I Association of Health Investigations
%X The pegylated interferon alpha and ribavirin treatment is well established therapy for hepatitis C virus (HCV) infection.During the treatment alanine aminotransferase (ALT) flare may be observed rarely.A 51-year-old female receiving pegylated interferon and ribavirin therapy for HCV infection, complained nausea, vomitingin seventh week of the therapy, and her ALT level was detected over 20 times above the normal level. Hepatitis B surfaceantigen, anti-nuclear antibody, anti-mitochondrial antibody, anti-double stranded DNA antibody and anti-hepatitisA virus IgM antibody were negative, and thyroid stimulating hormone was normal. HCV RNA level was 424 IU/ml. PEGIFN and ribavirin therapy was interrupted for three weeks, after liver enzyme level was detected less than 100U/L, thetreatment was resumed. The patient was followed up for 2 months, ALT flare was not observed.In conclusion, we present a rare case with ALT flare, while receiving pegylated interferon and ribavirin therapy forchronic HCV infection. J Microbiol Infect Dis 2012; 2(3): 121-123Key words: Pegylated interferon, ribavirin, ALT flare, hepatitis C virus
%K Pegylated interferon
%K ribavirin
%K ALT flare
%K hepatitis C virus
%U http://www.jcmid.org/upload/sayi/9/JMID-00611.pdf